| Filed | Form | Filer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-08-25 | SCHEDULE 13G | Stonepine Capital Management, LLC | — | — | view → |
| 2026-08-24 | SCHEDULE 13D/A | ALAFI CAPITAL CO LLC | 19.90% | 7,220,101 | view → |
| 2026-08-21 | SCHEDULE 13D/A | Bering Partners II GP, L.L.C. | 9.99% | 3,553,398 | view → |
| 2026-07-20 | SCHEDULE 13G | CVI Investments, Inc. | — | — | view → |
| 2026-07-10 | SCHEDULE 13D | ALAFI CAPITAL CO LLC | 17.10% | 5,242,996 | view → |
| 2026-07-02 | SCHEDULE 13D | Bering Partners II GP, L.L.C. | 6.90% | 2,113,513 | view → |
| 2026-06-30 | SCHEDULE 13D/A | Valence Investments SPV VI, LLC | — | 356,989 | view → |
| 2023-05-23 | SC | Flynn James E | — | — | view → |
| Filed | Form | Issuer | Stake | Shares | |
|---|---|---|---|---|---|
| 2026-10-08 | SCHEDULE 13D/A | ArriVent BioPharma, Inc. | 5.80% | 2,875,962 | view → |
| 2026-10-02 | SCHEDULE 13D | ADARx Pharmaceuticals, Inc. | 14.00% | 14,913,764 | view → |
| 2026-09-25 | SCHEDULE 13D | Electra Therapeutics, Inc. | 11.00% | 6,885,170 | view → |
| 2026-09-10 | SCHEDULE 13D/A | Braveheart Bio, Inc. | 13.50% | 12,175,159 | view → |
| 2026-08-18 | SCHEDULE 13D | BlossomHill Therapeutics, Inc. | 8.90% | 2,714,279 | view → |
| 2026-08-18 | SCHEDULE 13D | Braveheart Bio, Inc. | 17.20% | 12,175,159 | view → |
| 2026-08-10 | SCHEDULE 13D/A | MBX Biosciences, Inc. | — | 3,074,853 | view → |
| 2026-08-05 | SCHEDULE 13D | Yarrow Bioscience, Inc. | 9.97% | 266,306 | view → |
| 2026-07-29 | SCHEDULE 13D | Scribe Therapeutics, Inc. | 7.20% | 1,348,825 | view → |
| 2026-07-20 | SCHEDULE 13D/A | Q32 Bio Inc. | — | 4,127,987 | view → |
| 2026-06-24 | SCHEDULE 13D/A | Enliven Therapeutics, Inc. ELVN | — | 6,774,507 | view → |
| 2026-06-17 | SCHEDULE 13D/A | Enliven Therapeutics, Inc. ELVN | 10.93% | 7,634,630 | view → |
| 2026-06-15 | SCHEDULE 13D/A | Shattuck Labs, Inc. STTK | — | 9,021,127 | view → |
| 2026-06-01 | SCHEDULE 13D/A | Q32 Bio Inc. QTTB | — | 4,127,987 | view → |
| 2026-04-10 | SCHEDULE 13D/A | Adicet Bio, Inc. ACET | 8.80% | 844,787 | view → |
| 2026-01-27 | SCHEDULE | Corvus Pharmaceuticals, Inc. CRVS | 10.30% | 8,609,091 | view → |
| 2025-10-10 | SCHEDULE | Adicet Bio, Inc. ACET | 9.60% | 14,772,598 | view → |
| 2025-09-30 | SCHEDULE | MBX Biosciences, Inc. MBX | 9.00% | 4,002,887 | view → |
| 2025-07-21 | SCHEDULE | Passage BIO, Inc. PASG | 7.82% | 243,878 | view → |
| 2025-05-14 | SCHEDULE | Corvus Pharmaceuticals, Inc. CRVS | 12.20% | 9,785,423 | view → |
Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.
See pricing →